The Latest Breaking News from Calyxt

12 Health Care Stocks Moving In Thursday's Intraday Session

 

Benzinga · Apr 21, 2022

Calyxt's Return On Capital Employed Overview

According to Benzinga Pro data, during Q4, Calyxt (NASDAQ:CLXT) posted sales of $1.94 million. Earnings were up 3.42%, but Calyxt still reported an overall loss of $7.06 million.

Benzinga · Mar 9, 2022

Recap: Calyxt Q4 Earnings

Calyxt (NASDAQ:CLXT) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Calyxt beat estimated earnings by 53.66%, reporting an EPS of $-0.19 versus an estimate of $-0.41.

Benzinga · Mar 3, 2022